Detalhe da pesquisa
1.
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
N Engl J Med
; 389(3): 215-227, 2023 Jul 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37467497
2.
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature
; 586(7830): 589-593, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32785213
3.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med
; 385(3): 239-250, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34043894
4.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med
; 385(19): 1761-1773, 2021 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34525277
5.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med
; 383(27): 2603-2615, 2020 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33301246
6.
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
N Engl J Med
; 383(25): 2439-2450, 2020 12 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33053279
7.
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature
; 590(7844): E26, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33469216
8.
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
N Engl J Med
; 377(24): 2349-2362, 2017 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29236639
9.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
N Engl J Med
; 384(16): 1578, 2021 04 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33596351
10.
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
N Engl J Med
; 385(17): 1627-1629, 2021 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34525276
11.
Ending Race-Conscious College Admissions and Its Potential Impact on the Infectious Disease Workforce.
Open Forum Infect Dis
; 11(3): ofae083, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38444821
12.
Obstetric and neonatal outcomes in South Africa.
Vaccine
; 42(6): 1352-1362, 2024 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38310014
13.
Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
Hum Vaccin Immunother
; 18(1): 2037350, 2022 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35240933
14.
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.
Vaccine
; 40(12): 1872-1878, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35164991
15.
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study.
J Antimicrob Chemother
; 66(2): 363-70, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21148235
16.
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
Vaccine
; 39(32): 4545-4554, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34215452
17.
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Lancet Infect Dis
; 21(2): 263-274, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32891191
18.
Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
AIDS Care
; 22(6): 677-86, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20467943
19.
Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data.
Infect Dis Ther
; 9(3): 625-639, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32681472
20.
Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women.
Vaccine
; 38(29): 4542-4547, 2020 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32448618